The information on this website is for North America.

Medtrade Products Ltd announces CE certification for a ground-breaking solution for the management of postpartum haemorrhage

Author Archive

Medtrade Products Ltd announces CE certification for a ground-breaking solution for the management of postpartum haemorrhage

Monday, November 7th, 2022

Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field of obstetrics. Postpartum haemorrhage (PPH)…

Category: Latest News

CEO Russ Mably on Business Brunch with Des Machin – Cat Radio

Thursday, July 7th, 2022

Russ Mably, our CEO of Medtrade and Celox Medical products, attended an interview on Cat Radio to proudly discuss the highlights of Medtrade and the support provided to the crisis in Ukraine. Medtrade mobilised rapidly reacting to the situation in Ukraine and is manufacturing around the clock to help support the people of Ukraine. We…

Category: Latest News

CPJ and Medtrade to distribute CELOX lifesaving medical supplies in Ukraine

Monday, May 9th, 2022

New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies, designed to stop hemorrhaging within…

MEDTRADE RECEIVES EU MDR CERTIFICATION FOR THE CELOX CE RANGE

Thursday, March 17th, 2022

Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company of Celox Medical has been…

Medtrade awarded innovation grant to develop next generation haemostatic technology

Thursday, September 16th, 2021

Medtrade Products Ltd are proud to announce the successful award of an innovation and research project from the Medical Technology Enterprise Consortium (MTEC NCH – MTEC (mtec-sc.org). Despite fierce competition from numerous different companies, the U.S. Army Medical Material Development Activity (USAMMDA) selected Medtrade Products Ltd to create a product designed for military medical use, specifically…